Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer's Disease via Fusion of Clinical, Imaging and Omic Features.

TitleCascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer's Disease via Fusion of Clinical, Imaging and Omic Features.
Publication TypeJournal Article
Year of Publication2017
AuthorsSinganamalli A, Wang H, Madabhushi A
Corporate AuthorsAlzheimer’s Disease Neuroimaging Initiative
JournalSci Rep
Volume7
Issue1
Pagination8137
Date Published2017 08 15
ISSN2045-2322
KeywordsAged, Aged, 80 and over, Algorithms, Alzheimer Disease, Biomarkers, Case-Control Studies, Cognitive Dysfunction, Female, Genomics, Humans, Male, Models, Theoretical, Neuroimaging, Proteomics, Sensitivity and Specificity
Abstract

The introduction of mild cognitive impairment (MCI) as a diagnostic category adds to the challenges of diagnosing Alzheimer's Disease (AD). No single marker has been proven to accurately categorize patients into their respective diagnostic groups. Thus, previous studies have attempted to develop fused predictors of AD and MCI. These studies have two main limitations. Most do not simultaneously consider all diagnostic categories and provide suboptimal fused representations using the same set of modalities for prediction of all classes. In this work, we present a combined framework, cascaded multiview canonical correlation (CaMCCo), for fusion and cascaded classification that incorporates all diagnostic categories and optimizes classification by selectively combining a subset of modalities at each level of the cascade. CaMCCo is evaluated on a data cohort comprising 149 patients for whom neurophysiological, neuroimaging, proteomic and genomic data were available. Results suggest that fusion of select modalities for each classification task outperforms (mean AUC = 0.92) fusion of all modalities (mean AUC = 0.54) and individual modalities (mean AUC = 0.90, 0.53, 0.71, 0.73, 0.62, 0.68). In addition, CaMCCo outperforms all other multi-class classification methods for MCI prediction (PPV: 0.80 vs. 0.67, 0.63).

DOI10.1038/s41598-017-03925-0
Alternate JournalSci Rep
PubMed ID28811553
PubMed Central IDPMC5558022
Grant ListU01 AG024904 / AG / NIA NIH HHS / United States
UL1 TR002369 / TR / NCATS NIH HHS / United States
R01 CA202752 / CA / NCI NIH HHS / United States
R01 CA208236 / CA / NCI NIH HHS / United States
C06 RR012463 / RR / NCRR NIH HHS / United States
U24 CA199374 / CA / NCI NIH HHS / United States
R21 CA179327 / CA / NCI NIH HHS / United States
P30 AG010129 / AG / NIA NIH HHS / United States
R21 CA195152 / CA / NCI NIH HHS / United States
R01 DK098503 / DK / NIDDK NIH HHS / United States
Related Institute: 
Brain Health Imaging Institute (BHII)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065